Publication & Citation Trends
Publications
0 total
Signal Transduction Evaluating TBK 1 as a Therapeutic Target in Cancers with Activated IRF 3
Cited by 2
Semantic Scholar
Abstract 5436: Targeting oncoproteins via disruption of proteostasis: Identification of oncoprotein destabilizing agents using luciferase tagged oncoproteins
Cited by 0
Semantic Scholar
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor. OA
Cited by 23
Semantic Scholar
Development and Repurposing of Small-Molecule Kinase Inhibitors to Target Novel Leukemogenic TNK2 Mutations
Cited by 0
Semantic Scholar
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins OA
Cited by 1,346
Semantic Scholar
Evaluating TBK1 as a Therapeutic Target in Cancers with Activated IRF3 OA
Cited by 50
Semantic Scholar
Triazoloamides as potent γ-secretase modulators with reduced hERG liability.
Cited by 20
Semantic Scholar
Abstract 3714: Characterization of a selective focal adhesion kinase (FAK) inhibitor in a panel of glioblastoma cell lines identify rational drug-drug combination strategies
Cited by 2
Semantic Scholar
Triazoles as γ-secretase modulators.
Cited by 16
Semantic Scholar
Quinazolinones as γ-secretase modulators.
Cited by 18
Semantic Scholar
Research Topics
Ion channel regulation and function
(14)
Protein Degradation and Inhibitors
(11)
Histone Deacetylase Inhibitors Research
(10)
Nicotinic Acetylcholine Receptors Study
(7)
Ubiquitin and proteasome pathways
(6)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Oak Ridge National Laboratory
Howard Hughes Medical Institute
Harvard University
Universities UK